Omada Health (OMDA) Cash & Equivalents (2024 - 2026)

Omada Health's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $211.8 million for Q1 2026.

• In Q1 2026, Cash & Equivalents changed N/A year-over-year to $211.8 million; the TTM figure through Mar 2026 stood at $211.8 million (changed N/A YoY), while the FY2025 annual figure was $222.0 million, up 190.65% from the prior year.
• Cash & Equivalents came in at $211.8 million for Q1 2026 at Omada Health, down from $222.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $223.1 million in Q2 2025 to a low of $76.4 million in Q4 2024.
• A 3-year average of $186.4 million and a median of $211.8 million in 2026 frame the typical range for Cash & Equivalents.
• On a YoY basis, Cash & Equivalents climbed as much as 190.65% in 2025 and fell as far as 190.65% in 2025.
• Omada Health's Cash & Equivalents stood at $76.4 million in 2024, then soared by 190.65% to $222.0 million in 2025, then fell by 4.63% to $211.8 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $211.8 million, $222.0 million, and $198.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison